Futu Information on December 29 | the main index of Hong Kong stocks fell, with the Hang Seng Index closing down 0.88% at midday, the National Index down 1.1%, and the Hang Seng Technology Index down 1.54%.

By midday's close, Hong Kong stocks were up 509, down 1179, to close flat at 1157.

Plate aspectLarge-scale technology stocks fell generally, Tencent fell by more than 1%, Baidu fell by more than 2%, BABA fell by more than 2%, and JD.com Group fell by more than 1%.

Evergrande concept continues to reboundHengteng network rose by more than 30%, China Evergrande Group and China Evergrande New Energy Vehicle by about 1%.

Aviation stocks go higher against the trendAir China Limited rose more than 2%, while China Southern Airlines, China Eastern Airlines and Cathay Pacific Airways rose more than 1%.

Film and television stocks generally fell.Huaxia audio-visual education fell by more than 10%, Starlight Culture fell by nearly 10%, BABA Film fell by nearly 4%, NetEase, Inc Yun Music and Cat's Eye Entertainment fell by more than 1%.

In other aspects, education stocks, property management stocks, catering stocks led the decline, power stocks continued to decline.

Individual stocks$Hengteng Network (00136.HK) $It soared more than 30 per cent, with three directors entering the market in the middle of this month to buy a total of 58.3 million shares, accounting for about 0.6 per cent of the total share capital.

$Dongyue Group (00189.HK) $It rose nearly 3%, and the new 10, 000 tons of ╱ annual PVDF project was approved.

China Water (00855.HK) $It rose by more than 11%, and the proposed split of the water supply and direct drinking water business was won by the institution.

$New Oriental Education & Technology Group online (01797.HK) $It fell by more than 20%, and Yu Minhong's first show earned only 5 million.

$Pop Mart International (09992.HK) $It fell by more than 4% to an all-time low, and was recently fined 20,000 for not revising the emergency plan for safety accidents.

CICC: downgrade$Development Pharmaceutical Industry-B (09939.HK) $Rated to "neutral", the target price was lowered by 80% to HK $18.

CICC released a research report that downgraded Development Pharmaceutical-B to "neutral". Due to the failure of clinical analysis of Puclosamide, coupled with the rapid evolution of COVID-19 's drug research and development pattern and epidemic situation, the bank adjusted its income contribution forecast for COVID-19 indications, maintained its 2021 earnings forecast, lowered its 2022 earnings per share forecast, and reduced its target price from HK $86 to HK $18 per share.

Macquarie: reiterate$Yihai International (01579.HK) $The rating of "outperforming the market" was lowered to HK $30.

Macquarie issued a report that consumer demand will be lower than expected, affecting Yihai International's related party transactions and third-party business operations. The bank lowered its target price for Yihai International from HK $33 to HK $30, reiterating its "outperform" rating. Macquarie pointed out that the biggest disadvantage of Yihai International related party transactions will be the continued low sales of Haidilao International Holding and the downward trend in prices caused by the new hot pot soup formula. The bank lowered revenue growth from 25 per cent to 2 per cent in the second half of 2021 and lowered its profit forecasts by 3.1 per cent, 8.9 per cent and 11.4 per cent respectively from 2021 to 2023.

Half-day turnover TOP20